BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 16527604)

  • 1. Chromosome band 6q deletion pattern in malignant lymphomas.
    Taborelli M; Tibiletti MG; Martin V; Pozzi B; Bertoni F; Capella C
    Cancer Genet Cytogenet; 2006 Mar; 165(2):106-13. PubMed ID: 16527604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Array comparative genomic hybridization reveals a very high frequency of deletions of the long arm of chromosome 6 in testicular lymphoma.
    Bosga-Bouwer AG; Kok K; Booman M; Boven L; van der Vlies P; van den Berg A; van den Berg E; de Jong B; Poppema S; Kluin P
    Genes Chromosomes Cancer; 2006 Oct; 45(10):976-81. PubMed ID: 16865685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Codeletion of CDKN2 and MTAP genes in a subset of non-Hodgkin's lymphoma may be associated with histologic transformation from low-grade to diffuse large-cell lymphoma.
    Dreyling MH; Roulston D; Bohlander SK; Vardiman J; Olopade OI
    Genes Chromosomes Cancer; 1998 May; 22(1):72-8. PubMed ID: 9591637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A fluorescence in situ hybridization map of 6q deletions in acute lymphocytic leukemia: identification and analysis of a candidate tumor suppressor gene.
    Sinclair PB; Sorour A; Martineau M; Harrison CJ; Mitchell WA; O'Neill E; Foroni L
    Cancer Res; 2004 Jun; 64(12):4089-98. PubMed ID: 15205317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional deletion and amplification on chromosome 6 in a uveal melanoma case without abnormalities on chromosomes 1p, 3 and 8.
    van Gils W; Kilic E; Brüggenwirth HT; Vaarwater J; Verbiest MM; Beverloo B; van Til-Berg ME; Paridaens D; Luyten GP; de Klein A
    Melanoma Res; 2008 Feb; 18(1):10-5. PubMed ID: 18227702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple regions of allelic loss from chromosome arm 6q in malignant mesothelioma.
    Bell DW; Jhanwar SC; Testa JR
    Cancer Res; 1997 Sep; 57(18):4057-62. PubMed ID: 9307293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion 6q is not a characteristic marker of nodal lymphoplasmacytic lymphoma.
    Cook JR; Aguilera NI; Reshmi S; Huang X; Yu Z; Gollin SM; Abbondanzo SL; Swerdlow SH
    Cancer Genet Cytogenet; 2005 Oct; 162(1):85-8. PubMed ID: 16157207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of 6q deletion in Waldenstrom macroglobulinemia.
    Chang H; Qi X; Xu W; Reader JC; Ning Y
    Eur J Haematol; 2007 Sep; 79(3):244-7. PubMed ID: 17655703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletions at 11q23 in different lymphoma subtypes.
    Zhu Y; Monni O; Franssila K; Elonen E; Vilpo J; Joensuu H; Knuutila S
    Haematologica; 2000 Sep; 85(9):908-12. PubMed ID: 10980627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delineation of a minimal region of deletion at 6q16.3 in follicular lymphoma and construction of a bacterial artificial chromosome contig spanning a 6-megabase region of 6q16-q21.
    Henderson LJ; Okamoto I; Lestou VS; Ludkovski O; Robichaud M; Chhanabhai M; Gascoyne RD; Klasa RJ; Connors JM; Marra MA; Horsman DE; Lam WL
    Genes Chromosomes Cancer; 2004 May; 40(1):60-5. PubMed ID: 15034870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A combined strategy of conventional cytogenetics, fluorescent in situ hybridization and microsatellite polymerase chain reaction to analyze the deletion of chromosome 6 in laryngeal squamous cell carcinoma.
    Kang N; Li F; Fu W; Zhang J; Sun K
    Oncol Rep; 2007 Dec; 18(6):1379-85. PubMed ID: 17982620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel tumor suppressor loci on 6q22-23 in primary central nervous system lymphomas.
    Nakamura M; Kishi M; Sakaki T; Hashimoto H; Nakase H; Shimada K; Ishida E; Konishi N
    Cancer Res; 2003 Feb; 63(4):737-41. PubMed ID: 12591717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosome 6 abnormalities in ovarian surface epithelial tumors of borderline malignancy suggest a genetic continuum in the progression model of ovarian neoplasms.
    Tibiletti MG; Bernasconi B; Furlan D; Bressan P; Cerutti R; Facco C; Franchi M; Riva C; Cinquetti R; Capella C; Taramelli R
    Clin Cancer Res; 2001 Nov; 7(11):3404-9. PubMed ID: 11705855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of 6q16-q21 in human lymphoid malignancies: a mapping and deletion analysis.
    Jackson A; Carrara P; Duke V; Sinclair P; Papaioannou M; Harrison CJ; Foroni L
    Cancer Res; 2000 Jun; 60(11):2775-9. PubMed ID: 10850412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Delineation of 6q deletions in breast carcinoma cell lines by fluorescence in situ hybridization].
    Zhang Y; Zhou J; Weng L; Gu W
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Feb; 17(1):20-3. PubMed ID: 10653903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of candidate tumor-suppressor genes in 6q27 by combined deletion mapping and electronic expression profiling in lymphoid neoplasms.
    Steinemann D; Gesk S; Zhang Y; Harder L; Pilarsky C; Hinzmann B; Martin-Subero JI; Calasanz MJ; Mungall A; Rosenthal A; Siebert R; Schlegelberger B
    Genes Chromosomes Cancer; 2003 Aug; 37(4):421-6. PubMed ID: 12800155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 13q deletions in B-cell lymphoproliferative disorders: frequent association with translocation.
    Struski S; Helias C; Gervais C; Audhuy B; Zamfir A; Herbrecht R; Lessard M
    Cancer Genet Cytogenet; 2007 Apr; 174(2):151-60. PubMed ID: 17452258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allelic losses on chromosome 6q25 in Hodgkin and Reed Sternberg cells.
    Re D; Starostik P; Massoudi N; Staratschek-Jox A; Dries V; Thomas RK; Diehl V; Wolf J
    Cancer Res; 2003 May; 63(10):2606-9. PubMed ID: 12750286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytogenetic and interphase FISH studies in the diagnosis of malignant lymphomas].
    Hu XC; Bao LM; Zhu XZ; Irons RD; Fu H; Chen Y; Chen H; Zhao XM; Yang XM; Li J
    Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):45-8. PubMed ID: 17575693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The application of fluorescence in situ hybridization in detecting chronic myeloid leukemia].
    Qiu HR; Miao KR; Wang R; Qiao C; Zhang JF; Zhang SJ; Qian SX; Xu W; Li JY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):207-10. PubMed ID: 19350518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.